Search

everythinglearnresearchcommunity

for

Search:↓

Higher EULAR/ACR scores in SLE patients predict more organ damage.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

The 2012 criteria are better for diagnosing atypical lupus cases.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

RHUPUS should be considered in children with deforming arthritis.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

A young woman with severe symptoms was diagnosed with SLE and improved significantly after treatment.

Hydroxychloroquine may help delay skin damage in lupus patients.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

SLE patients experience two patterns of non-inflammatory symptoms: intermittent and persistent.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.